1
[1] Agarwal, A., Khan, A. I., & Anwer, F. (2024). Platelet transfusion. In StatPearls [Internet]. StatPearls Publishing.
2
[2] Allard, S. (2009). Blood transfusion. Medicine, 37(3), 172-176.
3
[3] Carson, J. L., Stanworth, S. J., Guyatt, G., Valentine, S., Dennis, J., Bakhtary, S., ... & Pagano, M. B. (2023). Red blood cell transfusion: 2023 AABB international guidelines. Jama, 330(19), 1892-1902.
4
[4] Statistik, B. P. (2025). Statistik Indonesia 2025: Statistical yearbook of Indonesia 2025 (Vol. 53). Badan Pusat Statistik.
5
[5] Aji Muhawarman. (2025). Kasus Kanker Diprediksi Meningkat 70 Persen pada 2050, Kemenkes Perkuat Deteksi Dini
6
[6] Aji Muhawarman. (2025). Nyamuk lebih mematikan daripada hewan buas. Kementerian Kesehatan Republik Indonesia
7
[7] Lee, E. J., & Lee, A. I. (2016). Thrombocytopenia. Primary Care: Clinics in Office Practice, 43(4), 543-557.
8
[8] Ramaiah, L., Erkens, T., Sirivelu, M., & Vitsky, A. (2025). Hematopoietic system. In Haschek and Rousseaux's handbook of Toxicologic pathology (pp. 337-436). Academic Press.
9
[9] Kaushansky, K. (2024). Thrombopoietin, the primary regulator of platelet production: from mythos to logos, a thirty-year journey. Biomolecules, 14(4), 489.
10
[10] Gauer, R. L., & Braun, M. M. (2012). Thrombocytopenia. American family physician, 85(6), 612-622.
11
[11] Jeon, K., Kim, M., Lee, J., Lee, J. S., Kim, H. S., Kang, H. J., & Lee, Y. K. (2020). Immature platelet fraction: a useful marker for identifying the cause of thrombocytopenia and predicting platelet recovery. Medicine, 99(7), e19096.
12
[12] Asghar, M. B., Akhtar, F., Mahmood, A., Rafique, N., Rana, N. A., & Khalid, U. B. (2023). Diagnostic accuracy of immature platelet fraction (IPF) to differentiate between thrombocytopenia due to peripheral destruction versus bone marrow failure. Age (years), 27(19.1), 30-24.
13
[13] Ali, I., Graham, C., & Dempsey-Hibbert, N. C. (2019). Immature platelet fraction as a useful marker in the etiological determination of thrombocytopenia. Experimental Hematology, 78, 56-61.
14
[14] Kaufman, R. M., Djulbegovic, B., Gernsheimer, T., Kleinman, S., Tinmouth, A. T., Capocelli, K. E., ... & Tobian, A. A. (2015). Platelet transfusion: a clinical practice guideline from the AABB. Annals of internal medicine, 162(3), 205-213.
15
[15] Metcalf, R. A., Nahirniak, S., Guyatt, G., Bathla, A., White, S. K., Al-Riyami, A. Z., ... & Stanworth, S. J. (2025). Platelet transfusion: 2025 AABB and ICTMG international clinical practice guidelines. JAMA, 334(7).
16
[16] Das SS, Sen S, Zaman RU, Biswas RN. (2021). Plateletpheresis in the Era of Automation: Optimizing Donor Safety and Product Quality Using Modern Apheresis Instruments. Indian Journal of Hematology and Blood Transfusion ;37:134–9.
https://doi.org/10.1007/s12288-020-01337-1.
17
[17] Hans, R., Sharma, R. R., & Marwaha, N. (2019). Effect of plateletpheresis on postdonation serum thrombopoietin levels and its correlation with platelet counts in healthy voluntary donors. Asian Journal of Transfusion Science, 13(1), 10-16.
18
[18] Indonesia, M. K. R. (2015). Standar Pelayanan Transfusi Darah. Pelayanan Transfusi Darah.
19
[19] Chopra, S., Kaur, P., Bedi, R. K., & Kaur, G. (2023). Effect of double dose plateletpheresis on target yield and donor platelet recovery. Hematology, Transfusion and Cell Therapy, 45(1), 16-24.
20
[20] Makroo, R. N., Fadadu, D., Agrawal, S., & Chowdhry, M. (2018). Double dose plateletpheresis: a savior to shrinking donor pool and platelet inventory management. Indian Journal of Hematology and Blood Transfusion, 34(4), 691-696.
21
[21] Thokala, R. P., Radhakrishnan, K., Anandan, A., & Panicker, V. K. (2016). Recovery of platelet count among apheresis platelet donors. Journal of clinical and diagnostic research: JCDR, 10(12), EC01.
22
[22] Rajput, S., Makroo, R. N., Chowdhry, M., & Thakur, U. K. (2021). Changes in hematological parameters post plateletpheresis: Single center study from North India. Transfusion and Apheresis Science, 60(6), 103283.
23
[23] Patel, K. B., Inaniya, K., & Padharia, D. P. (2023). Recovery period for attaining baseline haematological parameters after plateletpheresis donation-a cohort study. J Clin Diagn Res, 17(4).
24
[24] Jiang, H., Jin, Y., Shang, Y., Yuan, G., Liu, D., Li, J., ... & Zhou, F. (2021). Therapeutic plateletpheresis in patients with thrombocytosis: gender, hemoglobin before apheresis significantly affect collection efficiency. Frontiers in Medicine, 8, 762419.
25
[25] Elsayed, A., Elsayed, B., Elmarasi, M., Elsabagh, A. A., Elsayed, E., Elmakaty, I., & Yassin, M. (2024). Thrombopoietin receptor agonists in post-hematopoietic cell transplantation complicated by prolonged thrombocytopenia: a comprehensive review. ImmunoTargets and Therapy, 461-486.
26
[26] Hans, R., Sharma, R. R., & Marwaha, N. (2019). Effect of plateletpheresis on postdonation serum thrombopoietin levels and its correlation with platelet counts in healthy voluntary donors. Asian Journal of Transfusion Science, 13(1), 10-16.
27
[27] Rosyidah, R. A., Anjani, N., Hartini, W. M., & Mardiyaningsih, A. (2023). Perbedaan Jumlah Trombosit Pasca Transfusi Thrombocyte Concentrate Dan Thrombocyte Apheresis Pada Pasien Trombositopenia. Jurnal Kesehatan, 11(1), 169-182.
28
[28] Kariyawasan, C. C., Botenne, C. S., Balasuriya, B. L. T., Ruhunuhewa, U. S., Dissanayake, D. M. C., & Ranatunga, S. A. C. D. (2024). Diagnostic Utility of Immature Platelet Fraction (IPF) in Differentiating Thrombocytopenia Due to Increased Thrombopoietic Activity. Achievements and Challenges of Medicine and Medical Science Vol. 9, 60-73.
29
[29] Ding, S., Wang, M., Fang, S., Xu, H., Fan, H., Tian, Y., ... & Sun, X. (2025). Corrigendum: D-dencichine regulates thrombopoiesis by promoting megakaryocyte adhesion, migration and proplatelet formation. Frontiers in Pharmacology, 15, 1504076.
30
[30] Bajaj, H., Rajpal, T., Sharma, M., Singh, P., Hemal, A., & Kumar, V. (2024). Role of immature platelet fraction in etiological diagnosis of thrombocytopenia. Journal of Laboratory Physicians, 16(4), 496-500.
31
[31] Zhu, M., Sharma, P., Mete, M., Olcal, A., Ibrahim, I., Chen, W., & Bat, T. (2025). Absolute Immature Platelet Count: An Accessible Biomarker to Distinguish Aplastic Anemia and Immune Thrombocytopenia. International Journal of Laboratory Hematology, 47(2), 357-361.